Physician profile
Jared A Stone
NPI 1720429087
$1,517.76
in general payments reported to CMS, 2019-2025
14 companies · $448 in 2025
The $448 reported for 2025 was more than what 78% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $167 · 2023: $564 · 2024: $339 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $454.88 | 2022-2025 | |
| Novo Nordisk INC | $320.80 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $156.09 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $143.43 | 2022-2024 | Airsupra, Fasenra, Breztri |
| Corium, LLC | $110.60 | 2023-2024 | Azstarys |
| Idorsia Pharmaceuticals US INC | $58.26 | 2023-2024 | Quviviq |
| Antares Pharma, INC. | $50.68 | 2025 | Xyosted |
| Otsuka America Pharmaceutical, INC. | $47.95 | 2025 | Rexulti |
| Exact Sciences Corporation | $47.57 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $41.62 | 2024-2025 | Veozah |
| Baxter Healthcare | $27.06 | 2022 | |
| Abbott Laboratories | $22.25 | 2023 | Proclaim |
| Medtronic, INC. | $19.87 | 2025 | Venaseal |
| Glaxosmithkline, LLC. | $16.70 | 2023 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.